Roche gambled on an all-comer design for trials of its COPD candidate astegolimab, a move that may prove costly as it fails a phase 3 test.

Pay Increase Goes from 6% to 3% for All FCPS Staff Last-ditch attempt for 5% raises for teachers, support staff.